Huang Mingdong, Mazar Andrew P, Parry Graham, Higazi Abd Al-Roof, Kuo Alice, Cines Douglas B
State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, People's Republic of China.
Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):697-700. doi: 10.1107/S0907444905014174. Epub 2005 May 26.
Urokinase-type plasminogen activator (urokinase, uPA) and its receptor, uPAR, have been implicated in cell adhesion, migration, tissue remodelling and tumour-cell invasion. uPAR has three domains and is anchored to membranes by a glycosyl-phosphatidylinositol (GPI) anchor. Recombinant uPAR without its GPI anchor, soluble uPAR (suPAR), tends to oligomerize, making it difficult to crystallize. The amino-terminal fragment (ATF) of uPA is the major receptor-binding determinant in suPAR and binds to suPAR with nanomolar affinity, indistinguishable from membrane-bound uPAR. It is shown that uPA is capable of dissociating the oligomerization of suPAR and the crystallization of the suPAR-ATF complex is reported here. The resulting crystals diffract to 3.1 A using a synchrotron X-ray source.
尿激酶型纤溶酶原激活剂(尿激酶,uPA)及其受体uPAR,与细胞黏附、迁移、组织重塑和肿瘤细胞侵袭有关。uPAR有三个结构域,并通过糖基磷脂酰肌醇(GPI)锚定在细胞膜上。没有GPI锚的重组uPAR,即可溶性uPAR(suPAR),倾向于寡聚化,这使得其难以结晶。uPA的氨基末端片段(ATF)是suPAR中主要的受体结合决定因素,并且以纳摩尔亲和力与suPAR结合,这与膜结合的uPAR无法区分。研究表明,uPA能够解离suPAR的寡聚化,本文报道了suPAR-ATF复合物的结晶情况。使用同步加速器X射线源,所得晶体的衍射分辨率达到3.1埃。